+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Illumina Inc (ILMN) - Product Pipeline Analysis, 2021 Update

FEATURED COMPANIES

  • Affymetrix, Inc.
  • Agilent Technologies Inc
  • ChunLab Inc
  • GenMark Diagnostics Inc
  • JumpCode Genomics Inc
  • Luminex Corp
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and cancer. The company’s portfolio encompasses sequencing kits and reagents; sequencing tools and systems; microarray kits and reagents; molecular biology reagents; and arrays and reagents. It offers human whole-genome sequencing; microarray services; and instrument services, training, and consulting. Illumina serves pharmaceutical companies, academic institutions, genomic research centers, biotechnology companies, and clinical research organizations. The company sells its products through direct sales and distributors in the Americas, Asia-Pacific, Europe, the Middle East, and Africa. Illumina is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

Scope
  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Illumina Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Affymetrix, Inc.
  • Agilent Technologies Inc
  • ChunLab Inc
  • GenMark Diagnostics Inc
  • JumpCode Genomics Inc
  • Luminex Corp
Illumina Inc Company Overview
  • Illumina Inc Company Snapshot
  • Illumina Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Illumina Inc - Pipeline Analysis Overview
  • Business Description
  • Illumina Inc - Key Facts
  • Illumina Inc - Major Products and Services
  • Illumina Inc Pipeline Products by Development Stage
  • Illumina Inc Ongoing Clinical Trials by Trial Status
Illumina Inc Pipeline Products Overview
  • Blood-Based Test - Breast Cancer
  • Blood-Based Test - Breast Cancer Product Overview
  • Blood-Based Test - Breast Cancer Clinical Trial
  • Blood-Based Test - Lung Cancer
  • Blood-Based Test - Lung Cancer Product Overview
  • Blood-Based Test - Lung Cancer Clinical Trial
  • Companion Diagnostic Test - Brain Cancer
  • Companion Diagnostic Test - Brain Cancer Product Overview
  • Companion Diagnostic Test - Colorectal Cancer
  • Companion Diagnostic Test - Colorectal Cancer Product Overview
  • Companion Diagnostic Test - Head and Neck Squamous Cell Carcinoma
  • Companion Diagnostic Test - Head and Neck Squamous Cell Carcinoma Product Overview
  • Companion Diagnostic Test - Lung Cancer
  • Companion Diagnostic Test - Lung Cancer Product Overview
  • Companion Diagnostic Test - Melanoma
  • Companion Diagnostic Test - Melanoma Product Overview
  • Companion Diagnostic Test - Oncology
  • Companion Diagnostic Test - Oncology Product Overview
  • Companion Diagnostic Test - Prostate Cancer
  • Companion Diagnostic Test - Prostate Cancer Product Overview
  • Diagnostic Aid For Cancer Test (DAC)
  • Diagnostic Aid For Cancer Test (DAC) Product Overview
  • Diagnostic Test - Infectious Diseases
  • Diagnostic Test - Infectious Diseases Product Overview
  • Galleri - LDT
  • Galleri - LDT Product Overview
  • Galleri - LDT Clinical Trial
  • InfiniumDx CytoSNP-12 Assay
  • InfiniumDx CytoSNP-12 Assay Product Overview
  • Integrated MiniSeq System
  • Integrated MiniSeq System Product Overview
  • Lab-On-A-Chip
  • Lab-On-A-Chip Product Overview
  • LSD-100 Lysosomal Storage Enzyme Analyzer
  • LSD-100 Lysosomal Storage Enzyme Analyzer Product Overview
  • Minimal Residual Disease Test
  • Minimal Residual Disease Test Product Overview
  • MRSA Screening Test
  • MRSA Screening Test Product Overview
  • Next Generation Galleri
  • Next Generation Galleri Product Overview
  • NGS Diagnostic System
  • NGS Diagnostic System Product Overview
  • NGS-Based Transplant Diagnostic Assay
  • NGS-Based Transplant Diagnostic Assay Product Overview
  • Novaseq Dx
  • Novaseq Dx Product Overview
  • Point-Of-Care Diagnostic Device- HIV
  • Point-Of-Care Diagnostic Device- HIV Product Overview
  • Portable Benchtop Analyzer - Viral Load Assay
  • Portable Benchtop Analyzer - Viral Load Assay Product Overview
  • Prenatal Screening Test
  • Prenatal Screening Test Product Overview
  • TruSight NIPT
  • TruSight NIPT Product Overview
  • TruSight Oncology 500 - TP53 Companion Diagnostic Assay
  • TruSight Oncology 500 - TP53 Companion Diagnostic Assay Product Overview
  • TruSight Oncology Comprehensive
  • TruSight Oncology Comprehensive Product Overview
  • TruSight Oncology Comprehensive Clinical Trial
  • TruSight Tumor 170 CDx - LOXO-101
  • TruSight Tumor 170 CDx - LOXO-101 Product Overview
  • TruSight Tumor 170 CDx - LOXO-292
  • TruSight Tumor 170 CDx - LOXO-292 Product Overview
  • Verifi Prenatal Test
  • Verifi Prenatal Test Product Overview
Illumina Inc - Key Competitors

Illumina Inc - Key Employees
  • Illumina Inc - Key Employee Biographies
Illumina Inc - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Recent Developments
  • Illumina Inc, Recent Developments
  • Apr 29, 2021: Illumina To Webcast Upcoming Investor Conference
  • Apr 28, 2021: Illumina to donate US $60 Million in sequencing capabilities to establish a global pathogen genomics initiative
  • Apr 23, 2021: Illumina and Kartos to develop collaborative TP53 companion diagnostic
  • Apr 05, 2021: Illumina Announces Preliminary Revenue for First Quarter Fiscal Year 2021
  • Apr 01, 2021: FTC challenges Illumina’s proposed $7.1bn Grail acquisition
  • Mar 11, 2021: Illumina and Harvard Pilgrim Health Care real-world evidence study demonstrates cost-effectiveness of offering NIPT to all pregnant women
  • Feb 25, 2021: Multi-cancer early detection company GRAIL now hiring for state-of-the-art laboratory facility in Research Triangle Park
  • Jan 21, 2021: MGI concurs with UK court's ruling to invalidate Illumina's patent
  • Jan 11, 2021: New bioinformatics solution powers multi-omics discovery at massive scale
  • Jan 11, 2021: GRAIL announces collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to evaluate cancer early detection technology for minimal residual disease
Appendix
  • Methodology
  • About the Publisher
List of Tables
  • Illumina Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Illumina Inc Pipeline Products by Equipment Type
  • Illumina Inc Pipeline Products by Indication
  • Illumina Inc Ongoing Clinical Trials by Trial Status
  • Illumina Inc, Key Facts
  • Illumina Inc, Major Products and Services
  • Illumina Inc Number of Pipeline Products by Development Stage
  • Illumina Inc Pipeline Products Summary by Development Stage
  • Illumina Inc Ongoing Clinical Trials by Trial Status
  • Illumina Inc Ongoing Clinical Trials Summary
  • Blood-Based Test - Breast Cancer - Product Status
  • Blood-Based Test - Breast Cancer - Product Description
  • Blood-Based Test - Breast Cancer - Breast Cancer Screening Cohort for the Development of Assays for Early Cancer Detection: The STRIVE Study
  • Blood-Based Test - Lung Cancer - Product Status
  • Blood-Based Test - Lung Cancer - Product Description
  • Blood-Based Test - Lung Cancer - The SUMMIT Study: Cancer Screening Study with or Without Low Dose Lung CT to Validate a Multi-cancer Early Detection Test
  • Companion Diagnostic Test - Brain Cancer - Product Status
  • Companion Diagnostic Test - Brain Cancer - Product Description
  • Companion Diagnostic Test - Colorectal Cancer - Product Status
  • Companion Diagnostic Test - Colorectal Cancer - Product Description
  • Companion Diagnostic Test - Head and Neck Squamous Cell Carcinoma - Product Status
  • Companion Diagnostic Test - Head and Neck Squamous Cell Carcinoma - Product Description
  • Companion Diagnostic Test - Lung Cancer - Product Status
  • Companion Diagnostic Test - Lung Cancer - Product Description
  • Companion Diagnostic Test - Melanoma - Product Status
  • Companion Diagnostic Test - Melanoma - Product Description
  • Companion Diagnostic Test - Oncology - Product Status
  • Companion Diagnostic Test - Oncology - Product Description
  • Companion Diagnostic Test - Prostate Cancer - Product Status
  • Companion Diagnostic Test - Prostate Cancer - Product Description
  • Diagnostic Aid For Cancer Test (DAC) - Product Status
  • Diagnostic Aid For Cancer Test (DAC) - Product Description
  • Diagnostic Test - Infectious Diseases - Product Status
  • Diagnostic Test - Infectious Diseases - Product Description
  • Galleri - LDT - Product Status
  • Galleri - LDT - Product Description
  • Galleri - LDT - A Study to Evaluate the Galleri Blood Test in the Multi-cancer Early Detection Test
  • Galleri - LDT - Assessment of the Implementation of an Investigational Multi-cancer Early Detection Test into Clinical Practice: The PATHFINDER Study
  • Galleri - LDT - The Circulating Cell-free Genome Atlas Study
  • InfiniumDx CytoSNP-12 Assay - Product Status
  • InfiniumDx CytoSNP-12 Assay - Product Description
  • Integrated MiniSeq System - Product Status
  • Integrated MiniSeq System - Product Description
  • Lab-On-A-Chip - Product Status
  • Lab-On-A-Chip - Product Description
  • LSD-100 Lysosomal Storage Enzyme Analyzer - Product Status
  • LSD-100 Lysosomal Storage Enzyme Analyzer - Product Description
  • Minimal Residual Disease Test - Product Status
  • Minimal Residual Disease Test - Product Description
  • MRSA Screening Test - Product Status
  • MRSA Screening Test - Product Description
  • Next Generation Galleri - Product Status
  • Next Generation Galleri - Product Description
  • NGS Diagnostic System - Product Status
  • NGS Diagnostic System - Product Description
  • NGS-Based Transplant Diagnostic Assay - Product Status
  • NGS-Based Transplant Diagnostic Assay - Product Description
  • Novaseq Dx - Product Status
  • Novaseq Dx - Product Description
  • Point-Of-Care Diagnostic Device- HIV - Product Status
  • Point-Of-Care Diagnostic Device- HIV - Product Description
  • Portable Benchtop Analyzer - Viral Load Assay - Product Status
  • Portable Benchtop Analyzer - Viral Load Assay - Product Description
  • Prenatal Screening Test - Product Status
  • Prenatal Screening Test - Product Description
  • TruSight NIPT - Product Status
  • TruSight NIPT - Product Description
  • TruSight Oncology 500 - TP53 Companion Diagnostic Assay - Product Status
  • TruSight Oncology 500 - TP53 Companion Diagnostic Assay - Product Description
  • TruSight Oncology Comprehensive - Product Status
  • TruSight Oncology Comprehensive - Product Description
  • TruSight Oncology Comprehensive - Study Evaluate the Impact of Comprehensive Genomic Profiling (CGP) on Clinical Outcomes of Late-stage Cancer Patients
  • TruSight Tumor 170 CDx - LOXO-101 - Product Status
  • TruSight Tumor 170 CDx - LOXO-101 - Product Description
  • TruSight Tumor 170 CDx - LOXO-292 - Product Status
  • TruSight Tumor 170 CDx - LOXO-292 - Product Description
  • Verifi Prenatal Test - Product Status
  • Verifi Prenatal Test - Product Description
Illumina Inc, Key Employees
  • Illumina Inc, Key Employee Biographies
  • Illumina Inc, Other Locations
  • Illumina Inc, Subsidiaries
  • Illumina Inc, Joint Venture
  • Glossary
List of Figures
  • Illumina Inc Pipeline Products by Equipment Type
  • Illumina Inc Pipeline Products by Development Stage
  • Illumina Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
  • Thermo Fisher Scientific Inc
  • Roche Diagnostics International Ltd
  • Qiagen NV
  • Oxford Nanopore Technologies Ltd
  • Luminex Corp
  • JumpCode Genomics Inc
  • GenMark Diagnostics Inc
  • ChunLab Inc
  • Agilent Technologies Inc
  • Affymetrix, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll